We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TULP:NASDAQBloomia Holdings, Inc. Analysis

Data as of 2026-08-02 - not real-time

$3.27

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Bloomia Holdings (TULP) is trading at $3.27, well below its 20‑day, 50‑day and 200‑day moving averages (3.58, 3.68 and 3.90 respectively), indicating a persistent bearish price trend. The RSI of 38 suggests the stock is approaching oversold territory, yet the MACD remains bearish and the price sits near its technical support of $3.11, with resistance anchored around $3.82. On the fundamentals side, revenue grew 16% to $72.3 M, but margins are thin (gross margin 23.6%, operating margin –0.1%) and earnings are negative (trailing EPS –$1.38). The balance sheet is heavily leveraged, featuring $83 M of debt against just $0.9 M of cash (debt‑to‑equity > 1,000), and free cash flow is zero. Despite these challenges, the stock trades at a price‑to‑book of 0.96 and a DCF‑derived fair value of $27.02, implying a massive valuation gap. Volatility is extreme at nearly 70% over 30 days, beta is high (≈2.6), and average daily volume is only a few hundred shares, underscoring liquidity risk. The Fear & Greed Index shows “Extreme Greed,” but that sentiment is not reflected in TULP’s deteriorating fundamentals. In summary, the ticker is dramatically undervalued on paper but burdened by debt, weak profitability, and technical weakness, making it a high‑risk speculative play.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • price below all major moving averages
  • bearish MACD and RSI nearing oversold
  • extremely low trading volume

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • significant revenue growth but thin margins
  • massive debt load limiting operational flexibility
  • potential upside if debt reduction or restructuring occurs

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • price‑to‑book below 1 and DCF fair value far above market price
  • revenue growth indicating underlying business demand
  • speculative upside contingent on successful turnaround of profitability

Key Metrics & Analysis

Financial Health

Revenue Growth16.00%
Profit Margin0.99%
Debt/Equity1062.47
P/B Ratio1.0
Op. Cash Flow$12.2M

Technical Analysis

TrendBearish
RSI38.0
Support$3.11
Resistance$3.82
MA 20$3.57
MA 50$3.68
MA 200$3.90
MACDBearish
VolumeIncreasing
Fear & Greed Index92.88

Valuation

Fair Value$27.02
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.30
Volatility69.62%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.